Pharma Journalist -

Bell Biosystems declared the results of their latest preclinical safety study at the Biotech Showcase in San Francisco. The study managed to comply with USP <151> pyrogenicity…
Read More...

Miraca Life sciences declared that it intends to change its name to inform Diagnostics with effect from immediate Avista Capital partners had acquired the company in November. The new…
Read More...

TAI diagnostics that oversees the health of transplanted organs announced the final closing of $10 million Series A preferred equity financing that will aid ongoing research and…
Read More...

Attune Medical has acquired 510 (k) clearance from the US Food and Drug Administration for new EnsoETM that administers tube feeds medication while cooling or warming patients at the…
Read More...

Aimmune Therapeutics announced its plans for the upcoming year to report top-line results in February from a pivotal phase 3 PALISADE trial of AR101 for peanut allergy following the…
Read More...

IT solutions to the global life sciences market, Instem announces the purchase of  Provantis preclinical software solution suite by  Guangdong Lewwin Pharmaceutical Research Institute…
Read More...

Octapharma USA declared Neil Herson to come on board to join as Senior VP of National Accounts and market access. Former ASD Healthcare, Neil possesses 25 years of global pharmaceutical…
Read More...

Novaliq announces randomizing patients in its SEECASE Phase 2 clinical trial of NOV03 for treating dry eye disease. Novaliq is a pharmaceutical company delivering drugs that transforms…
Read More...

SMi Reports:4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED AT SMI’s DRUG DISCOVERY CONFERENCE 2018 SMi’s Drug Discovery conference taking place on 21st and 22nd March…
Read More...

Mitochondrial organisations comprising of the The Foundation for Mitochondrial Medicine (FMM), MitoAction, the Mitochondrial Medicine Society (MMS) and the United Mitochondrial Disease…
Read More...